α-glucosidase inhibitors with a phthalimide skeleton:: Structure-activity relationship study

被引:0
|
作者
Takahashi, H [1 ]
Sou, S [1 ]
Yamasaki, R [1 ]
Sodeoka, M [1 ]
Hashimoto, Y [1 ]
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
关键词
alpha-glucosidase; enzyme inhibitor; phthalimide; tetrachlorophthalimide; structure-activity relationship;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
alpha-Glucosidase inhibitors with a phthalimide skeleton were prepared. Structure-activity relationship studies indicated a critical role for the hydrophobicity of the substituent at the nitrogen atom of the phthalimide skeleton. Introduction of electron-withdrawing groups, including a nitro group and chlorine, influenced the activity. Optimization studies led us to design 4,5,6,7-tetrachluro-N-phenylphthalimide (CPOP) and its N-phenylalkyl derivatives. CPOP and 4.5,6,7-tetrachloro-N-(4-phenylbutyl)phthalimide (CP4P) proved to be more potent alpha-glucosidase inhibitors than the known inhibitor 1-deoxynojirimycin.
引用
收藏
页码:1494 / 1499
页数:6
相关论文
共 50 条
  • [31] Two-dimensional quantitative structure–activity relationship study on polyphenols as inhibitors of α-glucosidase
    Vesna Rastija
    Drago Bešlo
    Sonja Nikolić
    Medicinal Chemistry Research, 2012, 21 : 3984 - 3993
  • [32] Structure-activity relationship studies of sphingosine kinase inhibitors
    Raje, Mithun R.
    Kharel, Yugesh
    Lynch, Kevin R.
    Santos, Webster L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [33] Structure-Activity Relationship and Characterization of Novel Influenza Inhibitors
    Mohl, Gregory
    Liddle, Nathan
    Michaelis, David
    Busath, David
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 419A - 419A
  • [34] Structure-Activity Relationship of USP5 Inhibitors
    Mann, Mandeep K.
    Zepeda-Velazquez, Carlos A.
    Gonzalez-Alvarez, Hector
    Dong, Aiping
    Kiyota, Taira
    Aman, Ahmed M.
    Loppnau, Peter
    Li, Yanjun
    Wilson, Brian
    Arrowsmith, Cheryl H.
    Al-Awar, Rima
    Harding, Rachel J.
    Schapira, Matthieu
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15017 - 15036
  • [35] Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors
    Tahtouh, Tania
    Durieu, Emilie
    Villiers, Benoit
    Bruyere, Celine
    Thu Lan Nguyen
    Fant, Xavier
    Ahn, Kwang H.
    Khurana, Leepakshi
    Deau, Emmanuel
    Lindberg, Mattias F.
    Severe, Elodie
    Miege, Frederic
    Roche, Didier
    Limanton, Emmanuelle
    L'helgoual'ch, Jean-Martial
    Burgy, Guillaume
    Guiheneuf, Solene
    Herault, Yann
    Kendall, Debra A.
    Carreaux, Francois
    Bazureau, Jean-Pierre
    Meijer, Laurent
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (02) : 1396 - 1417
  • [36] Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study
    Azimi, Fateme
    Azizian, Homa
    Najafi, Mohammad
    Hassanzadeh, Farshid
    Sadeghi-aliabadi, Hojjat
    Ghasemi, Jahan B.
    Faramarzi, Mohammad Ali
    Mojtabavi, Somayeh
    Larijani, Bagher
    Saghaei, Lotfollah
    Mahdavi, Mohammad
    BIOORGANIC CHEMISTRY, 2021, 114
  • [37] Structure-activity relationship of a series of inhibitors of aromatase (AR)
    Shah, K.
    Owen, C. P.
    Ahmed, S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1372 - 1374
  • [38] Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship
    Bonafoux, Dominique F.
    Bonar, Sheri L.
    Clare, Michael
    Donnelly, Ann M.
    Glaenzer, Jeanette L.
    Guzova, Julia A.
    Huang, He
    Kishore, Nandidni N.
    Koszyk, Francis J.
    Lennon, Patrick J.
    Libby, Adam
    Mathialagan, Sumathy
    Oburn, David S.
    Rouw, Sharon A.
    Sommers, Cynthia D.
    Tripp, Catherine S.
    Vanella, Lori J.
    Weier, Richard
    Wolfson, Serge G.
    Huang, Horng-Chih
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (01) : 403 - 414
  • [39] Structure-Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase
    Zhou, Ling-Yun
    Peng, Jia-Le
    Wang, Jun-Ming
    Geng, Yuan-Yuan
    Zuo, Zhi-Li
    Hua, Yan
    MOLECULES, 2018, 23 (02):
  • [40] STRUCTURE-ACTIVITY RELATIONSHIP OF ABCC2 INHIBITORS
    Wissel, Gloria
    Kudryavtsev, Pavel
    Deng, Feng
    Wipf, Peter
    Xhaard, Henri
    Kidron, Heidi
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S103 - S104